Format

Send to

Choose Destination
Cancer Immunol Immunother. 2019 Mar 9. doi: 10.1007/s00262-019-02320-0. [Epub ahead of print]

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Author information

1
Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
2
Department of Medical Oncology, Leiden University Medical Center, Hippocratespad 21, 2333 ZD, Leiden, The Netherlands.
3
Departments of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
4
Department of Immunopathology, Landsteiner Laboratory, Amsterdam UMC and Swammerdam Institute for Life Sciences, Sanquin Research, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
5
Department of Pathology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
6
Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. vandeneertwegh@vumc.nl.
PMID:
30852622
DOI:
10.1007/s00262-019-02320-0

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center